-
-
-
-
-
-
-
QuidelOrtho reports preliminary Q1 2026 revenue of $615-620 million
-
-
-
-
-
-
-
Quidel Corp. (QDEL) PT Lowered to $55 at Raymond James
-
-
-
-
-
-
-
Quidel Corp (QDEL) Tops Q1 EPS by 13c, provides guidance
-
-
-
-
-
-
-
Jefferies Starts Quidel Corp. (QDEL) at Hold
-
-
-
-
-
-
-
QuidelOrtho (QDEL): VITROS Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/23: (SYPR) (SLAB) (EBSB) Higher; (INO) (QDEL) (EDAP) Lower (more...)
450,767 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

